Overview
Yohta Shimada practices practicing medicine in Tokyo, Japan.
Shimada is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Pompe Disease, GM1 Gangliosidosis, and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 41 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yohta Shimada
Is Yohta Shimada a top-rated expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)?
MediFind is an objective health platform that identifies experts based on real-world data. Yohta Shimada is classified as an Elite expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yohta Shimada participate in research or clinical trials?
Yes. Yohta Shimada has published 41 articles and abstracts on conditions like Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). You can view a list of Yohta Shimada's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Distinguished
- Mucopolysaccharidoses (MPS)Shimada isDistinguished. Learn about Mucopolysaccharidoses (MPS).
- Advanced
- GM1 GangliosidosisShimada isAdvanced. Learn about GM1 Gangliosidosis.
- Pompe DiseaseShimada isAdvanced. Learn about Pompe Disease.
- Experienced
- Bone Marrow TransplantShimada isExperienced. Learn about Bone Marrow Transplant.
- Fabry DiseaseShimada isExperienced. Learn about Fabry Disease.
- Farber LipogranulomatosisShimada isExperienced. Learn about Farber Lipogranulomatosis.
- GangliosidosisShimada isExperienced. Learn about Gangliosidosis.
- Pancreatic CancerShimada isExperienced. Learn about Pancreatic Cancer.